Page last updated: 2024-08-21

podophyllotoxin and propidium

podophyllotoxin has been researched along with propidium in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	1 (100.00)	2.80

Authors

Authors	Studies
Ahn, IH; Choi, IY; Choi, JR; Hwang, SG; Kang, AR; Kim, J; Kwon, JH; Lee, NG; Park, JK; Song, JY; Um, HD	1

Other Studies

1 other study(ies) available for podophyllotoxin and propidium

Article	Year
JNC-1043, a Novel Podophyllotoxin Derivative, Exerts Anticancer Drug and Radiosensitizer Effects in Colorectal Cancer Cells. Molecules (Basel, Switzerland), 2022, Oct-18, Volume: 27, Issue:20 Topics: Acetylcysteine; Annexin A5; Antineoplastic Agents; Apoptosis; Cell Line, Tumor; Cell Proliferation; Colorectal Neoplasms; Humans; Podophyllotoxin; Propidium; Radiation-Sensitizing Agents; Reactive Oxygen Species	2022

Article

Year

JNC-1043, a Novel Podophyllotoxin Derivative, Exerts Anticancer Drug and Radiosensitizer Effects in Colorectal Cancer Cells.

Molecules (Basel, Switzerland), 2022, Oct-18, Volume: 27, Issue:20

Topics: Acetylcysteine; Annexin A5; Antineoplastic Agents; Apoptosis; Cell Line, Tumor; Cell Proliferation; Colorectal Neoplasms; Humans; Podophyllotoxin; Propidium; Radiation-Sensitizing Agents; Reactive Oxygen Species

2022